Description

The Virtual Grand Rounds Series provides your institution with consistent, high-quality, one-hour educational programs, presented by the Massachusetts General Hospital Psychiatry Academy’s world-renowned faculty.


Led by Program Directors Jerrold F. Rosenbaum, MD, Psychiatrist in Chief at Massachusetts General Hospital, and Maurizio Fava, MD, Executive Vice Chair of the Psychiatry Dept. at Massachusetts General Hospital, the Virtual Grand Rounds Series allows doctors, residents, and medical students to conveniently acquire knowledge about clinical challenges and innovative treatment options for a variety of psychiatric disorders. Given the time constraints of today's clinical practice, the online format of the Virtual Grand Rounds Series means your medical staff can participate in real-time or choose to view the archived version whenever time allows. When viewed in live format, interactive features are enabled that let program faculty provide live feedback to questions and communicate directly with you and your staff.

Past Participant Testimonials:
"Great job, the word is getting out and more and more physicians are coming into the lecture hall to attend."
"I like that they are interactive, and on-demand."
"Asking questions worked remarkably well in real time. It was only 2-3 seconds from the time I pushed the 'enter' button to the time it arrived on Dr. Nierenberg's screen."

Schedule

Launch date

Topic

Speaker

1/25/12

 

How to Help a Colleague with a Problem: Psychoactive Substance Use among Physicians/Nurses

John Fromson, MD

2/8/2012

Exercise for Mood and Anxiety Disorders: Evidence and Strategies

Michael W. Otto, PhD

2/22/2012

Whose Game Is It, Anyway? Psychosocial Aspects of Youth Sports

 

Richard Ginsburg, PhD

3/7/2012 

Depression in Cardiac Patients

Jeffrey Huffman, MD

3/21/2012

 

A New Treatment Paradigm for Coping with Chronic Stress: The Relaxation Response Resiliency

John W. Denninger, MD, PhD

4/4/2012

Brain Evolution, Attachment Solutions and Healing

Gregory L. Fricchione, M.D.

4/18/2012

Child Cognitive Behavioral Therapy

Aude Henin, PhD

5/2/2012

Managing Metabolic Side Effects of Psychotropic Medication

David Henderson, MD

Pricing

$1,750 for an an eight-presentation subscription (Institutions)

$175 for an an eight-presentation subscription (Individuals)

Faculty

  • Director of Research, Benson-Henry Institute for Mind Body Medicine, Massachusetts General Hospital
    Associate Director of the MGH-McLean Adult Psychiatry Residency, Training Program
    Instructor of Psychiatry, Harvard Medical School

  • Associate Chief of Psychiatry;
    Director, Division of Psychiatry and Medicine, Massachusetts General Hospital
    Director, Benson-Henry Institute for Mind Body Medicine, Massachusetts General Hospital
    Professor of Psychiatry, Harvard Medical School
  • Director of Professional Development, Massachusetts General Hospital Psychiatry Academy
    Assistant Professor of Psychiatry, Harvard Medical School

  • Massachusetts General Hospital for Children, MGH Sport Concussion Clinic
    Clinical Assistant Professor of Psychology, MGH/Harvard Medical School
  • Director, Postgraduate Medical Education, Massachusetts General Hospital
    Assistant Professor of Psychiatry, Harvard Medical School
  • Associate Professor of Psychiatry, Harvard Medical School
    Director, Schizophrenia Clinical and Research Program, Massachusetts General Hospital
    Director, Chester M. Pierce, MD Division of Global Psychiatry
  • Co-Director, Child Cognitive-Behavioral Therapy Program, Massachusetts General Hospital
    Director, Cognitive Behavior Therapy Program, Clinical and Research Program in Pediatric Psychopharmacology, Massachusetts General Hospital
    Assistant Professor of Psychology in the Department of Psychiatry, Harvard Medical School
  • Director of Cardiac Psychiatry Research Program, Massachusetts General Hospital
    Assistant Professor of Psychiatry, Harvard Medical School

  • Director, Translational Research Program at the Center for Anxiety and Related Disorders, Boston University
    Professor of Psychology, Boston University

Troubleshooting

For instructions on accessing broadcasts and claiming credit, click here.

Prior to watching a broadcast, we encourage participants to check their system.  This can be done by visiting, http://mghc.me/systemtest.

Occasionally, participants will have difficulty watching our broadcasts.Please follow these instructions to troubleshoot the broadcast.

Still need help? Give us a call at (866) 644-7792 or email us at mghcme@partners.org.

CME Information

Release Date: January 25, 2012
Latest Review: Dr. John A. Fromson, on April 9, 2013
Expiration Date: May 1, 2014

To receive credit for this activity, listen to the presentation and complete the post-test and activity evaluation.

Accreditation
This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of McLean Hospital and Massachusetts General Hospital. McLean Hospital is accredited by the ACCME to provide continuing medical education (CME) for physicians.

McLean Hospital designates this live activity for a maximum of 8 AMA PRA Category 1 Credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.


Psychologists: The Massachusetts General Hospital, Department of Psychiatry is approved by the American Psychological Association to offer Continuing Education (CE) for psychologists. The Massachusetts General Hospital, Department of Psychiatry maintains responsibility for this program. This offering meets the criteria for 1 Continuing Education (CE) credit per presentation for psychologists.

Nurses: This program meets the requirements of the Massachusetts Board of Registration in Nursing (224 CMR 5.00) for 1 contact hour of nursing continuing education credit per presentation.

Social Workers: This program has been approved for 1 Social Work Continuing Education hour for relicensure per presentation, in accordance with 258 CMR. Collaborative of NASW and the Boston College and Simmons Schools of Social Work Authorization Number D 51021.

 


Policy on Faculty and Provider Disclosure
It is the policy of McLean Hospital that faculty and providers disclose real or apparent conflicts of interest relating to the topics of this educational activity. McLean Hospital has established policies in place that identify and resolve all conflicts of interest prior to this educational activity.


Planner Disclosures

The following planners of this activity have indicated that neither they nor their spouse/partner have a relevant financial relationship to disclose:

Jerrold F. Rosenbaum, MD, PhD:

John A. Fromson, MD:

Tristan Gorrindo, MD

Anan Nathif, EdM

 

The following planner of this activity has indicated that he or a member of his immediate family has a significant financial interest or affiliation with the manufacturer of a commercial product or provider of a commercial service which may affect the content of this presentation.  These disclosures may be germane to the content of the activity.

 

Maurizio Fava, MD

Advisory Board/Consulting

Abbott Laboratories; Affectis Pharmaceuticals AG; Alkermes, Inc.; Amarin Pharma Inc.; Aspect Medical Systems; AstraZeneca; Auspex Pharmaceuticals; Bayer AG; Best Practice Project Management, Inc.; BioMarin Pharmaceuticals, Inc.; Biovail Corporation; BrainCells Inc; Bristol-Myers Squibb; CeNeRx BioPharma; Cephalon, Inc.; Clinical Trials Solutions, LLC; CNS Response, Inc.; Compellis Pharmaceuticals; Cypress Pharmaceutical, Inc.; DiagnoSearch Life Sciences (P) Ltd.; Dinippon Sumitomo Pharma Co. Inc.; Dov Pharmaceuticals, Inc.; Edgemont Pharmaceuticals, Inc.; Eisai Inc.; Eli Lilly and Company; ePharmaSolutions; EPIX Pharmaceuticals, Inc.; Euthymics Bioscience, Inc.; Fabre-Kramer Pharmaceuticals, Inc.; Forest Pharmaceuticals, Inc.; GenOmind, LLC; GlaxoSmithKline; Grunenthal GmbH; i3 Innovus/Ingenis; Janssen Pharmaceutica; Jazz Pharmaceuticals, Inc.; Johnson & Johnson Pharmaceutical Research & Development, LLC; Knoll Pharmaceuticals Corp.; Labopharm Inc.; Lorex Pharmaceuticals; Lundbeck Inc.; MedAvante, Inc.; Merck & Co., Inc.; MSI Methylation Sciences, Inc.; Naurex, Inc.; Neuronetics, Inc.; NextWave Pharmaceuticals; Novartis AG; Nutrition 21; Orexigen Therapeutics, Inc.; Organon Pharmaceuticals; Otsuka Pharmaceuticals; PamLab, LLC.; Pfizer Inc.; PharmaStar; Pharmavite® LLC.; PharmoRx Therapeutics; Precision Human Biolaboratory; Prexa Pharmaceuticals, Inc.; Puretech Ventures;  PsychoGenics; Psylin Neurosciences, Inc.; Rexahn Pharmaceuticals, Inc.; Ridge Diagnostics, Inc.; Roche; RCT Logic, LLC; Sanofi-Aventis US LLC.; Sepracor Inc.; Servier Laboratories; Schering-Plough Corporation; Solvay Pharmaceuticals, Inc.; Somaxon Pharmaceuticals, Inc.; Somerset Pharmaceuticals, Inc.; Sunovion Pharmaceuticals; Synthelabo; Takeda Pharmaceutical Company Limited; Tal Medical, Inc.; Tetragenex Pharmaceuticals, Inc.; TransForm Pharmaceuticals, Inc.; Transcept Pharmaceuticals, Inc.; Vanda Pharmaceuticals, Inc.

 

Speaking/Publishing

Adamed, Co; Advanced Meeting Partners; American Psychiatric Association; American Society of Clinical Psychopharmacology; AstraZeneca; Belvoir Media Group; Boehringer Ingelheim GmbH; Bristol-Myers Squibb; Cephalon, Inc.; CME Institute/Physicians Postgraduate Press, Inc.; Eli Lilly and Company; Forest Pharmaceuticals, Inc.; GlaxoSmithKline; Imedex, LLC; MGH Psychiatry Academy/Primedia; MGH Psychiatry Academy/Reed Elsevier; Novartis AG; Organon Pharmaceuticals; Pfizer Inc.; PharmaStar; United BioSource,Corp.; Wyeth-Ayerst Laboratories

 

Research Support

Abbott Laboratories; Alkermes, Inc.; Aspect Medical Systems; AstraZeneca; BioResearch; BrainCells Inc.; Bristol-Myers Squibb; Cephalon, Inc.; CeNeRx BioPharma; Clinical Trials Solutions, LLC; Clintara, LLC; Covidien; Eli Lilly and Company; EnVivo Pharmaceuticals, Inc.; Euthymics Bioscience, Inc.; Forest Pharmaceuticals, Inc.; Ganeden Biotech, Inc.; GlaxoSmithKline; Icon Clinical Research; i3 Innovus/Ingenix; Johnson & Johnson Pharmaceutical Research & Development; Lichtwer Pharma GmbH; Lorex Pharmaceuticals; NARSAD; NCCAM; NIDA; NIMH; Novartis AG; Organon Pharmaceuticals; PamLab, LLC.; Pfizer Inc.; Pharmavite® LLC; Photothera; Roche; RCT Logic, LLC; Sanofi-Aventis US LLC; Shire; Solvay Pharmaceuticals, Inc.; Synthelabo; Wyeth-Ayerst Laboratories

 

Stock/Other Financial Options

Compellis Pharmaceuticals

 

Royalty/patent, other income:

Patent for SPCD and patent application for a combination of azapirones and bupropion in MDD, copyright royalties for the MGH CPFQ, SFI, ATRQ, DESS, and SAFER. Patent for research and licensing of SPCD with RCT Logic; Lippincott, Williams & Wilkins; World Scientific Publishing Co., Pte.Ltd

 


We are committed to giving learners the most comprehensive view of disclosure information. For this reason, in addition to listing the disclosures specific to this activity, we also maintain a database of global disclosures for all faculty who plan or speak at our activities. Biographical information for each facutly is also included. To view a specific speaker or planner’s global disclosure, please click on the appropriate link below.

John W. Denninger, MD, PhD

Gregory Fricchione, MD

John A. Fromson, MD

Richard D. Ginsburg, PhD

Tristan L. Gorrindo, MD

David C. Henderson, MD

Aude Henin, PhD

Jeffrey C. Huffman, MD

Michael W. Otto, PhD


Hardware/Software Specifications: 

This internet-based CME activity is best experienced using Internet Explorer 8+, Mozilla Firefox 3+, Safari 4+. This Web site requires that JavaScript and session cookies be enabled. Certain activities may require additional software to view multimedia, presentation, or printable versions of the content. These activities will be marked as such and will provide links to the required software. That software may be: Adobe Flash, Adobe Acrobat, Microsoft PowerPoint, and Windows Media Player.

Optimal System Configuration:
Flash Player: Adobe Flash Player 10.1+
Browser: Firefox 3+, Internet Explorer 8.0+, Safari 4.0+, or Google Chrome 7.0+
Operating System: Windows XP+ or Mac OS X 10.4+
Internet Connection: 1 Mbps or higher

Minimum Requirements:
Windows PC:
500-MHz Pentium II; Windows XP or higher; 128 MB RAM; Video Card at least 64MB of video memory; Sound Card at least 16-bit; Macromedia Flash Player 10 or higher, audio playback with speakers for programs with video content; Firefox 1.1+, Internet Explorer 7.0+, Safari 1.0+, Google Chrome, or Opera
Macintosh:
Mac OS X 10.3 or higher with latest updates installed; 1.83MHz Intel Core Duo or faster; RAM: 128MB or more; Video Card: at least 64MB of video memory; Sound Card: at least 16-bit